<code id='F1D16D14CA'></code><style id='F1D16D14CA'></style>
    • <acronym id='F1D16D14CA'></acronym>
      <center id='F1D16D14CA'><center id='F1D16D14CA'><tfoot id='F1D16D14CA'></tfoot></center><abbr id='F1D16D14CA'><dir id='F1D16D14CA'><tfoot id='F1D16D14CA'></tfoot><noframes id='F1D16D14CA'>

    • <optgroup id='F1D16D14CA'><strike id='F1D16D14CA'><sup id='F1D16D14CA'></sup></strike><code id='F1D16D14CA'></code></optgroup>
        1. <b id='F1D16D14CA'><label id='F1D16D14CA'><select id='F1D16D14CA'><dt id='F1D16D14CA'><span id='F1D16D14CA'></span></dt></select></label></b><u id='F1D16D14CA'></u>
          <i id='F1D16D14CA'><strike id='F1D16D14CA'><tt id='F1D16D14CA'><pre id='F1D16D14CA'></pre></tt></strike></i>

          hotspot

          hotspot

          author:fashion    Page View:66963
          Cambridge: AbbVie
          The pharma giant AbbVie spent nearly $4 million on lobbying in the first three months of 2022 — nearly a million dollars more than the company has ever spent in a single quarter. Ruby Wallau for STAT

          WASHINGTON — The pharma giant AbbVie spent nearly $4 million on lobbying in the first three months of 2022 alone — more than any other drugmaker spent in the same period, and nearly a million dollars more than the company spent in the same period last year.

          AbbVie was the seventh-highest corporate lobbying spender last quarter, ahead of giants like Lockheed Martin, CVS Health, and, AT&T, federal records show.

          advertisement

          The number is eye-popping even for the pharmaceutical industry, which is known for its omnipresence on Capitol Hill, and its nearly unlimited lobbying budgets.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Wildfire smoke exposes gaps in outdoor worker protections
          Wildfire smoke exposes gaps in outdoor worker protections

          ApersonwaitingforthesubwaywearsafilteredmaskassmokyhazefromwildfiresinCanadablanketsaneighborhoodinN

          read more
          Glen Campbell's doctor discusses his public struggle with Alzheimer's
          Glen Campbell's doctor discusses his public struggle with Alzheimer's

          GlenCampbellperformsinIndio,Calif.,in2008.MichaelBuckner/GettyImagesGlenCampbell’sdecades-longmusica

          read more
          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more

          The biotech scorecard for Q4: 16 stock

          RyanPierse/GettyImagesHereisSTAT’sbiotechscorecard,ourregularledgerofstock-movingbiotechevents,forth